.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Mallinckrodt
Accenture
Deloitte
AstraZeneca
Chinese Patent Office
McKinsey
Teva
QuintilesIMS
Harvard Business School

Generated: November 24, 2017

DrugPatentWatch Database Preview

Dipivefrin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for dipivefrin hydrochloride and what is the scope of dipivefrin hydrochloride freedom to operate?

Dipivefrin hydrochloride
is the generic ingredient in three branded drugs marketed by Falcon Pharms, Allergan, Akorn, and Bausch And Lomb, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for dipivefrin hydrochloride.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn
AKPRO
dipivefrin hydrochloride
SOLUTION/DROPS;OPHTHALMIC074382-001Sep 29, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Allergan
PROPINE
dipivefrin hydrochloride
SOLUTION/DROPS;OPHTHALMIC018239-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bausch And Lomb
DIPIVEFRIN HYDROCHLORIDE
dipivefrin hydrochloride
SOLUTION/DROPS;OPHTHALMIC074188-001May 19, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Falcon Pharms
DIPIVEFRIN HYDROCHLORIDE
dipivefrin hydrochloride
SOLUTION/DROPS;OPHTHALMIC073636-001Jun 30, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: dipivefrin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan
PROPINE
dipivefrin hydrochloride
SOLUTION/DROPS;OPHTHALMIC018239-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Allergan
PROPINE
dipivefrin hydrochloride
SOLUTION/DROPS;OPHTHALMIC018239-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Julphar
Cipla
Federal Trade Commission
Express Scripts
UBS
US Department of Justice
Cerilliant
Cantor Fitzgerald
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot